Clinical commissioning policy: Lonafarnib for Hutchinson-Gilford progeria syndrome (12 months of age and over)

Document first published:
Page updated:
Topic:
Publication type:
,

Lonafarnib is recommended to be available as a routine commissioning treatment option for Hutchinson-Gilford progeria syndrome (HGPS) within the criteria set out in this document.

Summary

PDF format. Published 26 August 2026.

Summary

PDF format. Published 26 August 2026.

Summary

PDF format. Published 26 August 2026.

Summary

PDF format. Published 26 August 2026.

Summary

PDF format. Published 26 August 2026.